REGN logo
REGN

Regeneron Pharmaceuticals Inc

Biotechnology

Regeneron Pharmaceuticals Inc (REGN) Earnings

Last reported
April 29, 2026
EPS estimate
$9.23
EPS actual
Revenue est.
$3.6B
Revenue actual